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Forty Wistar rats were divided into 5 groups, including the control group, the acute pancreatitis group (AP group, induced by
intraperitoneal injections of caerulein), and the AP group treated with baicalin, the AP group treated with LPS, and the AP group
treated with LPS and baicalin. Pathological damage of pancreatic tissue was scored with hematoxylin and eosin (HE) staining.
The mRNA expression of TNF-α was measured with semiquantitative RT-PCR, and activation of NF-κB was detected with ﬂow
cytometry assay. It was shown in the results that the expression of TNF-α mRNA, activation of NF-κB, and pathological score of
AP group were all obviously higher than those of control group (P<. 01). In AP group treated with LPS, further rise of these
values were observed (P<. 01). In the AP group treated with baicalin, activation of NF-κB decreased (P<. 05), and expression of
TNF-α mRNA also obviously decreased (P<. 01), while pancreatic pathological damage was alleviated at the same time (P<. 01);
similar results were observed in AP group treated with LPS and baicalin (P<. 01), which indicated that baicalin might be applied
to inhibit NF-κB activating and TNF-α expressing so as to treat AP.
Copyright © 2006 Dongbo Xue et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Acute pancreatitis (AP) is characteristic of serious patho-
genetic condition, with high mortality, and there is still no
breakthrough in treatment. Common mortal causes of AP
include systemic inﬂammatory response syndrome (SIRS)
and multiple organ dysfunction syndrome (MODS), and so
forth, which cannot be suﬃciently explained with the tradi-
tional pancreatic autodigestion theory. It has been proved by
a series of experiments in recent years that several inﬂam-
matory mediators (such as IL-1, IL-6, and TNF-α,e t c )a r e
related to the local and systemic tissue damages [1], and acti-
vation of these mediators are regulated by nuclear factor-κB
(NF-κB) [2]. NF-κB is a kind of DNA binding protein, tak-
ing part in various kinds of inﬂammatory and immune re-
sponses by adjusting gene expression of cytokine and adhe-
sion molecule [3, 4]. Research shows that NF-κB expression
increased in AP, and it played an important role in initiation
and development of AP [5]. Therefore, the subject how to re-
strain the generation of NF-κB and inﬂammatory mediators
becomes a new focus of AP treatment.
In clinical AP treatment, some traditional Chinese me-
dicinal prescriptions, such as Qing-Yi-Tang and Chai-Hu-
Tang, and so forth, have been proved to be eﬀective [6, 7].
According to chemical analysis, baicalin (5,6,7-trihydroxy-
ﬂavone-7-O-D-glucuronic acid. C21H18O11)i sa ne ﬀective
component in these prescriptions [8]. Baicalin is a kind of
ﬂavonoid compound extracted from dried root of Scutellaria
baicalensis Georgi, a kind of Origanum.I tf e a t u r e sv a r i o u s
eﬀects such as heat-clearing and detoxicating, antiinﬂamma-
tion,antiallergic,andsoforth[9].Inthispaper,theinﬂuence
of baicalin on NF-κB and the inﬂammatory mediator, for ex-
ample, TNF-α, are observed in order to clarify the eﬀects of
baicalin in treating AP and its possible mechanism.
MATERIALS AND METHODS
Reagents
The rabbit monoclonal antibody against NF-κBp 6 5w a s
obtained from Santa Cruz Biotechnology Inc (Santa Cruz,
Calif, USA). Fluorescein isothiocyanate (FITC)-labeled anti-
rabbit IgG antibody was purchased from Jackson Immuno
ResearchLaboratory(JacksonImmunoResearch,Westgrove,
Pa, USA). Caerulein, propidium iodide (PI), triton X100,
TRIzol, and lipopolysaccharide (LPS) were from Sigma Co2 Mediators of Inﬂammation
(Sigma, St Louis, Mo, USA). DL-2000 DNA marker, RNAase,
and reverse transcriptive-polymerase chain reaction (RT-
PCR)kitwerepurchasedfromPromegaCo(Promega,Madi-
son, Wis, USA). Baicalin (purity > 90%) was obtained from
Tongtai Pharmaceuticals Co (Tongtai, Sichuan, China).
Animalshandling
Male Wistar rats (250 ± 20g) were provided by the Animal
Research Center of the First Clinical College of Harbin Med-
ical University (Harbin, China). The experiments were car-
ried out on 40 rats, housed individually in wired bottomed
cages, at a room temperature of 18–22◦C using a 12-hour
light-dark cycle. All animals fasted for 12 hours before ma-
nipulation with free access to water. They were treated in ac-
cordance with the protocols approved by the local Animal
Use and Care Committee and executed according to the Na-
tional Animal Welfare Law.
AP was induced by 4 intraperitoneal injections of
caerulein (20μg/kg body weight) with 1-hour interval, at the
beginning, and consecutively the ﬁrst, the second, and the
third hours of the experiment. For control rats, only saline
solution was given. For the LPS-treated rats, the solution
of LPS (2mg/kg body weight) was given intraperitoneally
30 minutes after the last caerulein injection. To treat the
rats with baicalin, the solution of baicalin (50mg/kg body
weight) was given intraperitoneally 1, 12, 24, and 36 hours
after the ﬁnal caerulein injection.
The experimental animals were randomly divided into to
5 groups including the control group, the AP group, the AP
group treated with baicalin, the AP group treated with LPS,
and the AP group treated with baicalin and LPS.
Forty eight hours after the ﬁnal caerulein injection, rats
were anaesthetized with pentobarbital sodium (40mg/kg
body weight). Then, laparotomy was performed, and pan-
creas was rapidly removed for further analyses.
Scoringpathologicaldamageofpancreatictissue
The pancreas specimen was ﬁxed with 20% formaldehyde,
imbedded with paraﬃn, and then stained with hematoxylin
and eosin (HE) for tissue morphological observation. Patho-
logical damage of pancreatic tissue was evaluated semiquan-
titativelywithmodiﬁedGrewalmethod[10]byexclusiveper -
sonnel with the double-blind method under a light micro-
scope (Olympus, Japan).
TNF-αmRNAexpressionbyRT-PCR
Total RNA was extracted from pancreatic tissues by using
TRIzol reagent and was reversely transcribed into single-
strand cDNA, which was used as template for subsequent
polymerase chain reaction (PCR). The sequences of rat-
speciﬁc primers for TNF-α (415bp) were as follows: up-
stream primer, 5 GCCAATGGCATGGATCTCCAAAG3 
(P1); downstream primer, 5 CAGAGCAATGACTCCAAA-
GT3 (P2). Housekeeping gene β-actin (348bp) was used as
a control, upstream primer: 5 CATCACCATTGGCAATGA-
GCG3  (β1) and downstream primer: 5  CTAGAAGCATT-
TGCGGTCGGAC3  (β2). Conditions for ampliﬁcation were
as follows: preheating at 94◦C for 2 minutes; denaturing at
94◦C for 30 seconds, annealing at 55◦C for 30 seconds, and
extending at 68◦C for 30 seconds, for 30 cycles using a ther-
mal cycler (PerkinElmer, Mass, USA). Following these steps,
aﬁ n a le x t e n s i o nw a sc a r r i e do u ta t7 2 ◦C for 10 minutes. The
PCR product was separated by gel electrophoresis on 1.0%
agarose containing ethidium bromide and analyzed under





cleus suspension. Fresh pancreatic tissue was cut into pieces
of1.0mm 3 andwascentrifugedat200xgfor5minutes.After
10ml detergent solution containing 1% triton X100 added
and stored in a refrigerator at 4◦C for 18 hours, nucleus sus-
pension could be obtained by being ﬁltered through a 50μm
nylon mesh. Based on methods of Foulds [11]a n dD e p t a l a
et al[12], 1μL RNAase was added into 50μL nucleus suspen-
sion and water-bathed at 37◦C for 30 minutes.Then 40μL
NF-κB p65 monoclonal antibody was added and cultured
at room temperature for 20 minutes; 1μL FITC-labeled IgG
was added and cultured at room temperature for 20 min-
utes; 20μL PI was added and stored in a dark room for 30
minutes; then analyzed using a FACScan ﬂow cytometer (BD
Biosciences, USA).
Statisticalanalysis
Data were expressed as mean ± standard deviation (SD).
Comparison between groups was performed with analysis of
variance (ANOVA) and Student-Newman-Keuls test (q test).
Simple linear correlation analysis was applied to investigate
the relation between two parameters. Statistical signiﬁcance




In the control group, morphology of the pancreas was nor-
mal, the lobule structure existed, and mesenchyma was clear,
with a pathological score of 0.375 ± 0.04. In the AP group,
pancreatic congestion and edema were observed, and the
pancreatic cells were basically in normal shapes. Lobular
mesenchymal rarefaction, edema, and inﬂammatory cell in-
ﬁltration occurred, which were the main manifestations of
acute edematous pancreatitis (mild AP) and with a patho-
logical score of 3.5 ± 0.75. When compared with the con-
trol group, the diﬀerence was signiﬁcant (P<. 01). In the































3: AP group treated with baicalin
4: AP group treated with LPS
5: AP group treated with baicalin and LPS
Signiﬁcantly diﬀerent (P<. 01) from control
Signiﬁcantly diﬀerent (P<. 05) from AP group
Signiﬁcantly diﬀerent (P<. 01) from AP group
Signiﬁcantly diﬀerent (P<0.5) from AP group
treated with LPS
Figure 1: Pathological score of pancreatic tissue.
edema and inﬂammatory cell inﬁltration was alleviated as
compared with the AP group (P<. 05).
In the AP group treated with LPS, hemorrhagic and
necrotic spots were found sporadic in pancreatic tissue, with
cell membrane dissolved and nucleus disappeared. Acinus
and lobule structure were not clear. Around necrotic focus,
numerous leukocyte and monocyte inﬁltration could be ob-
served, which were main manifestations of acute necrotiz-
ing pancreatitis (severe AP), with a pathological score of
7.0±0.75, and pathological changes were remarkablyheavier
than that of the AP group (P<. 01); while in the AP group
treated with baicalin and LPS, the lobule structure was de-
stroyed, with acinus arranging in disorder. There were a lot
of inﬂammatory cell inﬁltrations, which were still manifes-
tations of acute necrotizing pancreatitis (with a pathological
score of 5.75 ± 1.25), but pathological changes were obvi-
ously alleviated (compared with the AP group treated with
LPS, P<. 05) (see Figure 1).
EffectsofbaicalinonTNF-αmRNAof
pancreatictissue
Semiquantitative analysis was carried out for mRNA expres-
sion of target gene of pancreatic tissue with the optical den-
sity ratio of the target gene/β-actin. TNF-α mRNA was ex-
pressedatalowlevel(0.72±0.10)inthecontrolgroup;inthe
AP group, the TNF-α mRNA level increased to 1.94 ± 0.23;




































Lane 1: control group
Lane 2: AP group
Lane 3: AP group treated with baicalin
Lane 4: AP group treated with LPS
Lane 5: AP group treated with baicalin and LPS
12345
Signiﬁcantly diﬀerent (P<. 01) from control
Signiﬁcantly diﬀerent (P<. 01) from AP group
Signiﬁcantly diﬀerent (P<. 01) from AP group
Signiﬁcantly diﬀerent (P<. 05) from AP group
treated with LPS
(b)
Figure 2: The mRNA expressions of TNF-α assessed with semi-
quantitive RT-PCR.
1.59 ± 0.16, which is obviously lower than that of the AP
group(P<. 01). In the AP group treated with LPS, it reached
3.79 ± 0.40, and when treated with baicalin, the level de-
creased to 3.35 ± 0.35, which makes signiﬁcant diﬀerence
when compared with the group treated with LPS (P<. 05)
(see Figure 2).
EffectsofbaicalinonactivationofNF-κB
In the control group, activation of NF-κBi nn o r m a lp a n c r e -
aticnucleuswasinalowlevel(< 5%),andintheAPgroup,it
increased obviously to 49.38% ± 5.9%. After treatment with
baicalin, it decreased to 40.46% ± 7.6% (versus AP group,
P<. 05). In the AP group treated with LPS, the activation
levelofNF-κBreached62.8%±8.38%,andwhentreatedwith
baicalin, it also decreased obviously to 51.58%±6.05 (versus
















































































































3: AP group treated with baicalin
4: AP group treated with LPS
5: AP group treated with baicalin and LPS
Signiﬁcantly diﬀerent (P<. 1) from control
Signiﬁcantly diﬀerent (P<. 5) from AP group
Signiﬁcantly diﬀerent (P<. 1) from AP group
Signiﬁcantly diﬀerent (P<. 5) from AP group
treated with LPS
(b)
Figure 3: The NF-κB activation detected with ﬂow cytometry assay.
DISCUSSION
At present, pathogenesis of AP is still unclear, which leads
to lack of proper treatment in AP therapeutic strategy. The
traditional hypotheses such as pancreatic autodigestion the-
ory or microcirculatory disturbance theory cannot satisfac-
torily explain the mechanism that AP develops SIRS, MODS,
and even death. However, the inﬂammatory mediator the-
ory proposed recently provides a new clue for AP research
[13]. It is explained in this theory that in the early stage
of AP, the abnormal-activated pancreatin damages adjacent
pancreatic cells and leads to local inﬁltration of inﬂamma-
tory cells. Activated inﬂammatory cells such as macrophage,
neutrophil, and pancreatic acinar cells produce and release
proinﬂammatory cytokines [14]. The rising degree of in-
ﬂammatory cytokines is closely associated with the severity
of AP, and it is these inﬂammatory cytokines that result in
SIRS and MODS.
Itisshowninthestudythatamongvariousinﬂammatory
mediators related with AP, TNF-α plays a key role and is an
importantindexthatindicatestheseverityofAP[15].There-
forepathologicaldamageofAPmaybealleviatedbyrestrain-
ing TNF-α expression. This assumption has been conﬁrmed
in research of some scholars. For example, Grewal et al [10]
reported that blocking TNF-α with anti-TNF-α polyclonal
antibody could signiﬁcantly decrease the severity of AP in
rats. Fijen et al [16] had succeeded in reducing proinﬂam-
matory cytokines such as TNF-α, IL-1, and IL-8 in blood
with the depressor obtained by activating mitogen-activated
protein kinase (MAPK) with p38 cytomin (mitogen), and al-
leviated inﬂammatory response caused by endotoxin, which
eventually increased the survival rate of patients.
Generation of TNF-α is adjusted by NF-κB as there are
binding sites of NF-κB on the TNF-α promoter [17]. NF-
κB is a protein with the gene-transcription regulation eﬀect,
which can participate in regulation of many inﬂammatoryDongbo Xue et al 5
cytokines [18]. It is proved in research that activation of NF-
κB can result in increased expression of cytokines such as
TNF-α, monocyte chemoattractant protein-1 (MCP-1) and
intercellular adhesion molecule-1 (ICAM-1), leading to im-
mune and inﬂammatory responses in organisms [19]. It is
proposed by Altavilla et al [20] that NF-κB activated by lipid
peroxide could increase generation of TNF-α, while NF-κB
and TNF-α decreased after using lipid peroxide inhibitors.
In our previous study, NF-κB activation, TNF-α mRNA
expression, and pathological score were measured 12, 24,
36, and 72 hours after inducing AP to clarify the relation-
ship among them. Results showed that in each time point,
there was relatively close correlation among NF-κBa c t i v a -
tion, TNF-α mRNA, and pathological score [21]. In this ex-
periment, relationship among them was studied again. Af-
ter inducing AP, NF-κB was activated signiﬁcantly (P<. 01),
while expression of TNF-α mRNA and the pathological score
of pancreatic damage also increased obviously. Correlation
analysis of NF-κBa n dT N F - α mRNA showed relatively high
correlation between them (with a correlation coeﬃcient of
0.7423, P<. 05); there was also relatively close correlation
between expression of TNF-α and pathological score, with
a correlation coeﬃcient of 0.7154 (P<. 05). In order to
further explore the regulating eﬀect of NF-κBa c t i v a t i o no n
TNF-α, LPS was applied as the stimulator to activate NF-κB
inthisexperiment[22].AfterAPwasinducedwithcaerulein,
large dosage of LPS was injected intraperitoneally. The result
showed that LPS strengthened NF-κB activation, and expres-
sion of TNF-α mRNA obviously increased simultaneously
and resulted in more severe pathological damage, which sug-
gests that in AP, activation of NF-κB may enhance expression
of TNF-α mRNA and participate in aggravation of pancre-
atic damage. Hence, it can be inferred that inhibiting acti-
vation of NF-κB may reduce expression of proinﬂammatory
genes, and alleviate inﬂammatory response and pancreatic
tissue damage, which may have positive sense for AP therapy.
In traditional Chinese medicine, some important pre-
scriptions have been successfully applied in AP treatment,
in which one of the mechanisms is to suppress inﬂamma-
tory response. Baicalin is an important active ingredient in
these prescriptions [23]. It is shown in modern pharmaco-
logical studies that baicalin features multiple eﬀects, such
as broad-spectrum antibacterial, immune regulation, antitu-
mor, antioxidation, and inducing apoptosis [24]. More re-
search has focused on exploring antiinﬂammatory naturally
occurring drugs. Eﬀects of baicalin on inﬂammatory media-
tors have also been studied more than ever. In research of Lo
et al [25] on lung injury caused by endotoxin, it was discov-
ered that baicalin could decrease contents of IL-1β,T N F - α,
and MCP-1 in serum, which was similar to the antiinﬂam-
mation eﬀect of dexameson. In research of Shen et al [26]
on peripheral blood leucocytes of patients with inﬂamma-
tion, results showed that baicalin had antiinﬂammation ef-
fects via decreasing myeloperoxidase (MPO) and inhibit-
ing leucocyte adhesion. It was proved in in vitro study that
baicalin could inhibit T lymphocyte proliferation, decreas-
ing expression of inﬂammatory cytokines such as IL-1, IL-
6, TNF, and macrophage inﬂammatory protein (MIP) [27].
In our study, eﬀects of baicalin on inﬂammatory mediator-
TNF-α and its regulating factor NF-κBi np a n c r e a t i ct i s s u e
of rats were studied. It was found that in the AP group, af-
ter treatment with baicalin, activation of NF-κB decreased
(P<. 05), and expression of TNF-α mRNA also signiﬁ-
cantly decreased (P<. 01), while pancreatic pathological
damage was alleviated at the same time (P<. 05); simi-
lar results were observed in the AP group treated with LPS
and baicalin. These results indicate that baicalin can in-
hibit NF-κB and the generation of inﬂammatory mediator in
pancreatic tissue, and eventually results in alleviated patho-
logical changes in AP. Therefore, baicalin has helpful eﬀects
in treating AP.
Generally, proinﬂammatory cytokine, such as TNF-α,
play an important role in pathogenesis of AP. However, gen-
eration of inﬂammatory mediator is regulated by the tran-
scription factor NF-κB. Baicalin extracted from traditional
Chinese medicine can treat AP via decreasing NF-κBa n d
TNF-α.
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